FDA Inspection
Cytovance Biologics Inc.Cytovance Biologics Inc. – FDA Inspection, Jun 17, 2026
Record Details
This FDA Inspection record concerns Cytovance Biologics Inc., with an inspection on June 17, 2026, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 56631e33-d2ff-4f1a-bdb8-d7a325ef8bd9
Inspection Facts
- Inspection number
- 1322570
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Cytovance Biologics Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 27, 2018 | Not classified | Dallas District Office | |
| July 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cytovance Biologics Inc.
- FDA Inspection 1089182 - 2019-05-09
- FDA Inspection 1078729 - 2018-04-27
- FDA Inspection 1026556 - 2017-07-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.